Pre-existing immunity to pathogenic Listeria monocytogenes does not prevent induction of immune responses to feline immunodeficiency virus by a novel recombinant Listeria monocytogenes vaccine

Vaccine

Volumn 23, Issue 12, 2005, Pages 1479-1490

  Stevens, Rosemary ^a   LaVoy, Alora ^a   Nordone, Shila ^a   Burkhard, MaryJo ^b   Dean, Gregg A ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Feline immunodeficiency virus; HIV; Listeria monocytogenes

Indexed keywords

DNA VACCINE; DRUG CARRIER; GAG PROTEIN; GAMMA INTERFERON; GLYCOPROTEIN; GLYCOPROTEIN GP 100; GLYCOPROTEIN GP 40; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOGLOBULIN A; PLASMID DNA; PLASMID VECTOR; POLYPROTEIN; PROTEIN ANTIBODY; PROTEIN P17; PROTEIN P45; RECOMBINANT VACCINE; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL IMMUNITY; CAT DISEASE; CELL LYSATE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG DETERMINATION; DRUG EXPOSURE; DRUG SCREENING; DRUG SOLUBILITY; ENZYME LINKED IMMUNOSPOT ASSAY; EUKARYOTE; FECES; FELINE IMMUNODEFICIENCY VIRUS; FEMALE; GENE CASSETTE; GENE FREQUENCY; GENE INDUCTION; GENETIC TRANSFECTION; GRAM POSITIVE BACTERIUM; HOST; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOGENICITY; INFECTION PREVENTION; LISTERIA MONOCYTOGENES; LYMPH NODE; MALE; MONKEY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN SECRETION; PROVOCATION TEST; SALIVA; SPLEEN; TARGET CELL; VAGINA SECRETION; VALIDATION PROCESS; VIRAL GENE THERAPY; VIRUS REPLICATION; VIRUS TRANSMISSION; WILD TYPE;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CATS; DISEASE MODELS, ANIMAL; FECES; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; FEMALE; GENE PRODUCTS, ENV; GENE PRODUCTS, GAG; IMMUNODEFICIENCY VIRUS, FELINE; IMMUNOGLOBULIN A; LISTERIA MONOCYTOGENES; SALIVA; VACCINES, SYNTHETIC; VAGINA; VIRAL PROTEINS; VIRAL VACCINES;

EID: 12844251353     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.09.033     Document Type: Article

References (66)

1. B. Pron, C. Boumaila, and F. Jaubert Dendritic cells are early cellular targets of Listeria monocytogenes after intestinal delivery and are involved in bacterial spread in the host Cell Microbiol 3 5 2001 331 340
2. A. Paschen, K.E. Dittmar, and R. Grenningloh Human dendritic cells infected by Listeria monocytogenes: induction of maturation, requirements for phagolysosomal escape and antigen presentation capacity Eur J Immunol 30 12 2000 3447 3456
3. T. Liu, H. Nishimura, T. Matsuguchi, and Y. Yoshikai Differences in interleukin-12 and -15 production by dendritic cells at the early stage of Listeria monocytogenes infection between BALB/c and C57 BL/6 mice Cell Immunol 202 1 2000 31 40
4. A. Kolb-Maurer, I. Gentschev, and H.W. Fries Listeria monocytogenes-infected human dendritic cells: uptake and host cell response Infect Immun 68 6 2000 3680 3688
5. S.H. Kaufmann Immunity to intracellular bacteria Annu Rev Immunol 11 129 1993 129 163
6. D.K. Bishop, and D.J. Hinrichs Adoptive transfer of immunity to Listeria monocytogenes. The influence of in vitro stimulation on lymphocyte subset requirements J Immunol 139 6 1987 2005 2009
7. K. Lukacs, and R.J. Kurlander MHC-unrestricted transfer of antilisterial immunity by freshly isolated immune CD8 spleen cells J Immunol 143 11 1989 3731 3736
8. S.H. Kaufmann, M.M. Simon, and H. Hahn Specific Lyt 123 cells are involved in protection against Listeria monocytogenes and in delayed-type hypersensitivity to listerial antigens Transplant Rev 18 130 1974 130 191
9. S.H. Kaufmann, and H. Hahn Biological functions of t cell lines with specificity for the intracellular bacterium Listeria monocytogenes in vitro and in vivo J Exp Med 150 4 1979 1033 1038
10. S.H. Kaufmann, E. Hug, U. Vath, and L.G. De Specific lysis of Listeria monocytogenes-infected macrophages by class II-restricted L3T4+ T cells Eur J Immunol 17 2 1987 237 246
11. M.E. Mielke, S. Ehlers, and H. Hahn T-cell subsets in delayed-type hypersensitivity, protection, and granuloma formation in primary and secondary Listeria infection in mice: superior role of Lyt-2+ cells in acquired immunity Infect Immun. 56 8 1988 1920 1925
12. M.E. Mielke, G. Niedobitek, H. Stein, and H. Hahn Acquired resistance to Listeria monocytogenes is mediated by Lyt-2+ T cells independently of the influx of monocytes into granulomatous lesions J Immunol 141 9 1988 3203 3207
13. D.M. Magee, and E.J. Wing Cloned L3T4+ T lymphocytes protect mice against Listeria monocytogenes by secreting IFN-gamma J Exp Med 167 4 1988 1459 1471
14. R. Schafer, D.A. Portnoy, S.A. Brassell, and Y. Paterson Induction of a cellular immune response to a foreign antigen by a recombinant Listeria monocytogenes vaccine J Immunol 153 7 1994 3116 3122
15. E.R. Jensen, H. Shen, F.O. Wettstein, R. Ahmed, and J.F. Miller Recombinant Listeria monocytogenes as a live vaccine vehicle and a probe for studying cell-mediated immunity Immunol Rev 158 147 1997 147 157
16. L.A. Zenewicz, K.E. Foulds, J. Jiang, X. Fan, and H. Shen Nonsecreted bacterial proteins induce recall CD8 T cell responses but do not serve as protective antigens J Immunol 169 10 2002 5805 5812
17. L.M. Weiskirch, and Y. Paterson Listeria monocytogenes: a potent vaccine vector for neoplastic and infectious disease Immunol Rev 158 159 1997 159 169
18. S. Daugelat, C.H. Ladel, B. Schoel, and S.H. Kaufmann Antigen-specific T-cell responses during primary and secondary Listeria monocytogenes infection Infect Immun 62 5 1994 1881 1888
19. Z.K. Pan, G. Ikonomidis, D. Pardoll, and Y. Paterson Regression of established tumors in mice mediated by the oral administration of a recombinant Listeria monocytogenes vaccine Cancer Res 55 21 1995 4776 4779
20. Z.K. Pan, G. Ikonomidis, A. Lazenby, D. Pardoll, and Y. Paterson A recombinant Listeria monocytogenes vaccine expressing a model tumour antigen protects mice against lethal tumour cell challenge and causes regression of established tumours Nat Med 1 5 1995 471 477
21. H. Shen, M.K. Slifka, M. Matloubian, E.R. Jensen, R. Ahmed, and J.F. Miller Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell-mediated immunity Nat Med 1 5 1995 471 477
22. F.R. Frankel, S. Hegde, J. Lieberman, and Y. Paterson Induction of cell-mediated immune responses to human immunodeficiency virus type 1 Gag protein by using Listeria monocytogenes as a live vaccine vector J Immunol 155 10 1995 4775 4782
23. M. Rayevskaya, N. Kushnir, and F.R. Frankel Anti-human immunodeficiency virus-gag CD8+ memory T cells generated in vitro from Listeria-immunized mice Immunology 109 3 2003 450 460
24. N.C. Pedersen, and J.E. Barlough Clinical overview of feline immunodeficiency virus J Am Vet Med Assoc 199 10 1991 1298 1305
25. M. Bendinelli, M. Pistello, and S. Lombardi Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen Clin Microbiol Rev 8 1 1995 87 112
26. J.H. Elder, and T.R. Phillips Feline immunodeficiency virus as a model for development of molecular approaches to intervention strategies against lentivirus infections Adv Virus Res 45 1995 225 247
27. J.H. Elder, and T.R. Phillips Molecular properties of feline immunodeficiency virus (FIV) Infect Agents Dis 2 6 1993 361 374
28. B.J. Willett, J.N. Flynn, and M.J. Hosie FIV infection of the domestic cat: an animal model for AIDS Immunol Today 18 4 1997 182 189
29. E.W. Uhl, T.G. Heaton-Jones, R. Pu, and J.K. Yamamoto FIV vaccine development and its importance to veterinary and human medicine: a review. FIV vaccine 2002 update and review Vet Immunol Immunopathol 90 3-4 2002 113 132
30. J.S. Elyar, M.C. Tellier, J.M. Soos, and J.K. Yamamoto Perspectives on FIV vaccine development Vaccine 15 12-13 1997 1437 1444
31. M. Gardner, J. Yamamoto, and M. Marthas SIV and FIV vaccine studies at UC Davis: 1991 update AIDS Res Hum Retroviruses 8 8 1992 1495 1498
32. O. Jarrett, J.K. Yamamoto, and J.C. Neil Feline immunodeficiency virus as a model for AIDS vaccination Aids 4 suppl. 1 1990 S163 S165
33. C.M. Johnson, B.A. Torres, H. Koyama, and J.K. Yamamoto Tenth anniversary perspectives on AIDS. FIV as a model for AIDS vaccination AIDS Res Hum Retroviruses 10 3 1994 225 228
34. J.S. Yang, R.V. English, and J.W. Ritchey Molecularly cloned feline immunodeficiency virus NCSU1 JSY3 induces immunodeficiency in specific-pathogen-free cats J Virol 70 5 1996 3011 3017
35. S.F. Park, and G.S. Stewart High-efficiency transformation of Listeria monocytogenes by electroporation of penicillin-treated cells Gene 94 1 1990 129 132
36. A. Jalanko, I. Palva, and Soderlund Restriction maps of plasmids pUB110 and pBD9 Gene 14 4 1981 325 328
37. S. Horinouchi, and B. Weisblum Nucleotide sequence and functional map of pE194, a plasmid that specifies inducible resistance to macrolide, lincosamide, and streptogramin type B antibodies J Bacteriol 150 2 1982 804 814
38. M. Geiser, R. Cebe, D. Drewello, and R. Schmitz Integration of PCR fragments at any specific site within cloning vectors without the use of restriction enzymes and DNA ligase Biotechniques 31 1 2001 88 90 92
39. G. Dietrich, A. Bubert, and I. Gentschev Delivery of antigen-encoding plasmid DNA into the cytosol of macrophages by attenuated suicide Listeria monocytogenes Nat Biotechnol 16 2 1998 181 185
40. M.J. Burkhard, C.K. Mathiason, T. Bowdre, and E.A. Hoover Feline immunodeficiency virus Gag- and Env-specific immune responses after vaginal versus intravenous infection AIDS Res Hum Retroviruses 17 18 2001 1767 1778
41. R. Stevens, K.E. Howard, S. Nordone, M.J. Burkhard, and G.A. Dean Oral immunization with recombinant Listeria monocytogenes controls virus load after vaginal challenge with feline immunodeficiency virus J Virol. 78 15 2004 8210 8218
42. G.A. Dean, A. LaVoy, and M.J. Burkhard Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT Vet Immunol Immunopathol 100 1-2 2004 49 59
43. A. Bubert, Z. Sokolovic, S.K. Chun, L. Papatheodorou, A. Simm, and W. Goebel Differential expression of Listeria monocytogenes virulence genes in mammalian host cells Mol Gen Genet 261 2 1999 323 336
44. J. Lieberman, and F.R. Frankel Engineered Listeria monocytogenes as an AIDS vaccine Vaccine 20 15 2002 2007 2010
45. S.A. Bishop, C.R. Stokes, T.J. Gruffydd-Jones, C.V. Whiting, and D.A. Harbour Vaginal and rectal infection of cats with feline immunodeficiency virus Vet Microbiol 51 3-4 1996 217 227
46. J.G. Bucci, R.V. English, H.L. Jordan, T.A. Childers, M.B. Tompkins, and W.A. Tompkins Mucosally transmitted feline immunodeficiency virus induces a CD8+ antiviral response that correlates with reduction of cell-associated virus J Infect Dis 177 1 1998 18 25
47. J.G. Bucci, D.H. Gebhard, T.A. Childers, R.V. English, M.B. Tompkins, and W.A. Tompkins The CD8+ cell phenotype mediating antiviral activity in feline immunodeficiency virus-infected cats is characterized by reduced surface expression of the CD8 beta chain J Infect Dis 178 4 1998 968 977
48. M.J. Burkhard, L.A. Obert, L.L. O'Neil, L.J. Diehl, and E.A. Hoover Mucosal transmission of cell-associated and cell-free feline immunodeficiency virus AIDS Res Hum Retroviruses 13 4 1997 347 355
49. D.H. Gebhard, J.L. Dow, T.A. Childers, J.I. Alvelo, M.B. Tompkins, and W.A. Tompkins Progressive expansion of an L-selectin-negative CD8 cell with anti-feline immunodeficiency virus (FIV) suppressor function in the circulation of FIV-infected cats J Infect Dis 180 5 1999 1503 1513
50. T.R. Moench, K.J. Whaley, T.D. Mandrell, B.D. Bishop, C.J. Witt, and R.A. Cone The cat/feline immunodeficiency virus model for transmucosal transmission of AIDS: nonoxynol-9 contraceptive jelly blocks transmission by an infected cell inoculum Aids 7 6 1993 797 802
51. L.L. O'Neil, M.J. Burkhard, L.J. Diehl, and E.A. Hoover Vertical transmission of feline immunodeficiency virus Semin Vet Med Surg (Small Anim) 10 4 1995 266 278
52. L.L. O'Neil, M.J. Burkhard, and E.A. Hoover Frequent perinatal transmission of feline immunodeficiency virus by chronically infected cats J Virol 70 5 1996 2894 2901
53. L.A. Obert, and E.A. Hoover Feline immunodeficiency virus clade C mucosal transmission and disease courses AIDS Res Hum Retroviruses 16 7 2000 677 688
54. L.A. Obert, and E.A. Hoover Relationship of lymphoid lesions to disease course in mucosal feline immunodeficiency virus type C infection Vet Pathol 37 5 2000 386 401
55. D.R. Burton, and D.C. Montefiori The antibody response in HIV-1 infection Aids 11 suppl. A 1997 S87 S98
56. D.R. Burton, and P.W. Parren Vaccines and the induction of functional antibodies: time to look beyond the molecules of natural infection? Nat Med 6 2 2000 123 125
57. T.R. Fouts, A. Trkola, M.S. Fung, and J.P. Moore Interactions of polyclonal and monoclonal anti-glycoprotein 120 antibodies with oligomeric glycoprotein 120-glycoprotein 41 complexes of a primary HIV type 1 isolate: relationship to neutralization AIDS Res Hum Retroviruses 14 7 1998 591 597
58. J.P. Moore, P.W. Parren, and D.R. Burton Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development J Virol 75 13 2001 5721 5729
59. P. Poignard, E.O. Saphire, P.W. Parren, and D.R. Burton gp120: biologic aspects of structural features Annu Rev Immunol 19 2001 253 274
60. Q.J. Sattentau, and J.P. Moore Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer J Exp Med 182 1 1995 185 196
61. Q.J. Sattentau, S. Zolla-Pazner, and P. Poignard Epitope exposure on functional, oligomeric HIV-1 gp41 molecules Virology 206 1 1995 713 717
62. M. Hense, E. Domann, and S. Krusch Eukaryotic expression plasmid transfer from the intracellular bacterium Listeria monocytogenes to host cells Cell Microbiol 3 9 2001 599 609
63. S. Cherpelis, X. Jin, and A. Gettie DNA-immunization with a V2 deleted HIV-1 envelope elicits protective antibodies in macaques Immunol Lett 79 1-2 2001 47 55
64. I.K. Srivastava, L. Stamatatos, and E. Kan Purification, characterization, and immunogenicity of a soluble trimeric envelope protein containing a partial deletion of the V2 loop derived from SF162, an R5-tropic human immunodeficiency virus type 1 isolate J Virol 77 20 2003 11244 11259
65. R.S. Friedman, F.R. Frankel, Z. Xu, and J. Lieberman Induction of human immunodeficiency virus (HIV)-specific CD8 T-cell responses by Listeria monocytogenes and a hyperattenuated Listeria strain engineered to express HIV antigens J Virol 74 21 2000 9987 9993
66. H.G. Bouwer, H. Shen, X. Fan, J.F. Miller, R.A. Barry, and D.J. Hinrichs Existing antilisterial immunity does not inhibit the development of a Listeria monocytogenes-specific primary cytotoxic T-lymphocyte response Infect Immun 67 1 1999 253 258